Skip to main content

Sustainability

Environmental responsibility through evidence and disciplined scope

NEUVIOR treats sustainability as an operating responsibility that requires a defined boundary, a measured baseline and records that can support each public claim.

Current approach | Measure before claiming impactResearch record | Historical work completedFuture targets | Publish only with a verified baseline

Operating standard

A commitment becomes credible when its boundary is measurable.

NEUVIOR does not publish unaudited impact scores, invented carbon reductions or renewable energy claims as proof of current performance.

Each statement should identify the entity, activity, period, method and evidence it covers.

01

Define

Set the organisational and operational boundary for the measurement.

02

Measure

Use a documented method and preserve the underlying records.

03

Report

Publish the result with its period, scope and limitations.

Research record

Feasibility work is evidence of investigation, not operating impact.

NEUVIOR retains a completed, bounded feasibility record in its research archive. It is not under active commercial development, and confidential technical and funding details are not restated on this website.

The record supports a research history. It does not support claims of active manufacturing, emissions reduction or commercial deployment.

01

Feasibility question

A defined research question was examined through bounded feasibility work.

Historical record
02

Completed study

The feasibility period is complete and should be described in the past tense.

Historical status
03

Current position

The completed work remains in the research archive rather than the active product portfolio.

Current status

Supplier readiness

Environmental evidence should mature with the company.

As operations, suppliers and infrastructure expand, NEUVIOR intends to build proportionate measurement, procurement expectations and reporting controls.

Future ambition must remain separate from a verified current footprint.

Human decision requiredProceed only inside an evidenced and governed scope.
01

Current boundary

Record the activities and suppliers actually within scope.

02

Evidence gap

Identify missing baseline, supplier or methodology data before setting a public result.

03

Progression gate

Publish a target or outcome only when the supporting method and governance are ready.

RESEARCH RECORD + CLAIM BOUNDARY

See the research record, and where the claim stops.

These publisher and partner pages preserve a dated record of historical NEUVIOR research activity. NEUVIOR does not restate confidential technical or funding details, and publication does not establish capability, performance or a live product.

  1. Biorenewables Development CentrePartner announcement

    NEUVIOR research record

    A partner hosted record covering bounded NEUVIOR pharmaceutical materials research.

    Open the partner research record
  2. Yorkshire PostRelease derived reporting

    NEUVIOR research record

    A dated Yorkshire Post record covering bounded NEUVIOR pharmaceutical manufacturing waste research.

    See the project coverage

NEUVIOR Insights and After Publication reflections are company or founder analysis. Publisher records evidence publication, not endorsement, adoption, product readiness, savings or clinical outcomes.

Make the next step useful

Bring the problem that needs a clearer decision.

Tell us what is stuck, what decision you need to make and what a better outcome would change. We will connect you to the most relevant NEUVIOR, PHARMORIS, media or investor route.

QUESTIONS · ANSWERED DIRECTLY

The useful answers, in one place.

Browse every question
01What is NEUVIOR?

NEUVIOR is a pharmaceutical company registered in Scotland. It is building capabilities across medicines intelligence, governed technology and longer term development. PHARMORIS is its immediate product priority.

02What does NEUVIOR build today?

NEUVIOR is developing PHARMORIS, a human-governed medicines operations system in controlled, non-production development. It is intended to connect evidence, decisions, accountable work and value review. No independent TRL, deployment, customer adoption or clinical validation is claimed.

03What is PHARMORIS by NEUVIOR?

PHARMORIS is a configurable medicines operations system under controlled development. It is designed to help authorised teams progress medicine opportunities from evidence linked to its source, through an owned ActionCase, a human decision, delivery and review.

04Who founded NEUVIOR?

Varun Sharma is the Founder, CEO and CTO of NEUVIOR and leads the company and PHARMORIS product architecture.

05Where does NEUVIOR have a presence?

NEUVIOR works across Glasgow, London and Mumbai. Glasgow is the company origin and registered Scottish base. London supports commercial activity led by the founder. Mumbai supports market engagement in India and relationships across the pharmaceutical sector. These are different forms of presence. They do not imply three registered offices or regulated facilities.